Seasoned Executive to Lead Strategy Across Capital Markets, Partner and Customer Development, and Global Operations SINGAPORE and SAN DIEGO, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Limited (NASDAQ: ...

Valneva's CEO Thomas Lingelbach and CFO Peter Bühler will discuss the Company's commercial portfolio of vaccines, which is expected to generate €160 - €170 million in revenues in 2024, and highlight ...

Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patient ...

A live webcast of the conference presentation will be accessible through Repligen's Investor Relations website at www.repligen.com, and will be available for replay for a limited period of time ...

Erin Whaley, Tammy Ward Woffenden and Paul M. Mahoney Jr. of Troutman Pepper Locke LLP discuss key market and legal ...

Shares of JPMorgan Chase & Co. JPM slipped 0.49% to $240.85 Monday, on what proved to be an all-around mixed trading session ...

Mexico raised $7.5 billion in the US market in January last year and followed it with a €2 billion ($2.07 billion) sale in ...

Wolfe Research has recently raised JPMorgan Chase & Co (JPM) stock to Outperform rating, as announced on January 3, 2025, according to Finviz. Earlier, on November 20, 2024, Oppenheimer had reduced ...

Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced that Chief Executive ...

Michael Barr, vice chair for supervision for the U.S. Federal Reserve and the leader of the U.S. effort behind the so-called Basel III endgame to lift capital requirements for banks, said he would ...

“Xenon” and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner. Contacts: For ...

The Board is also pleased to announce that Julie Chakraverty will join the Board as a Non-Executive Director and a member of the Finance and Safety & Operational Readiness Committees with effect from ...